33.37
price up icon3.99%   1.28
after-market 시간 외 거래: 32.85 -0.52 -1.56%
loading
전일 마감가:
$32.09
열려 있는:
$31.97
하루 거래량:
1.28M
Relative Volume:
1.31
시가총액:
$2.47B
수익:
$13.17M
순이익/손실:
$-199.06M
주가수익비율:
-12.18
EPS:
-2.74
순현금흐름:
$-156.53M
1주 성능:
+5.07%
1개월 성능:
+10.97%
6개월 성능:
-16.93%
1년 성능:
-8.73%
1일 변동 폭
Value
$31.89
$33.44
1주일 범위
Value
$31.09
$33.44
52주 변동 폭
Value
$26.74
$46.00

Xenon Pharmaceuticals Inc Stock (XENE) Company Profile

Name
명칭
Xenon Pharmaceuticals Inc
Name
전화
(604) 484-3300
Name
주소
200 - 3650 GILMORE WAY, BURNABY
Name
직원
327
Name
트위터
Name
다음 수익 날짜
2024-11-06
Name
최신 SEC 제출 서류
Name
XENE's Discussions on Twitter

XENE을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
XENE
Xenon Pharmaceuticals Inc
33.37 2.47B 13.17M -199.06M -156.53M -2.74
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Xenon Pharmaceuticals Inc Stock (XENE) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-05-07 개시 Chardan Capital Markets Buy
2025-02-11 개시 Deutsche Bank Buy
2024-10-10 재개 Raymond James Outperform
2024-10-01 개시 H.C. Wainwright Buy
2024-01-04 개시 Citigroup Buy
2023-12-08 개시 Robert W. Baird Outperform
2023-10-24 재개 Cantor Fitzgerald Overweight
2023-04-25 개시 Cantor Fitzgerald Overweight
2022-12-14 개시 Goldman Buy
2022-12-12 개시 Cowen Outperform
2022-11-28 개시 Wells Fargo Overweight
2022-10-19 개시 Raymond James Outperform
2022-08-29 개시 BofA Securities Buy
2022-07-21 개시 JP Morgan Overweight
2021-10-28 개시 RBC Capital Mkts Outperform
2020-10-02 개시 SVB Leerink Outperform
2020-07-21 개시 Needham Buy
2020-06-01 재개 Jefferies Buy
2020-03-25 개시 Wedbush Outperform
2020-01-08 개시 William Blair Outperform
2019-09-20 개시 Guggenheim Buy
2018-08-08 재확인 Stifel Buy
2017-03-13 개시 Jefferies Buy
2016-10-21 개시 Stifel Buy
2016-09-26 개시 Guggenheim Buy
2016-04-14 재확인 Jefferies Buy
2015-10-30 재개 Jefferies Buy
2014-12-02 개시 Canaccord Genuity Buy
모두보기

Xenon Pharmaceuticals Inc 주식(XENE)의 최신 뉴스

pulisher
Jun 18, 2025

Long Term Trading Analysis for (XENE) - news.stocktradersdaily.com

Jun 18, 2025
pulisher
Jun 15, 2025

Xenon Pharmaceuticals Target of Unusually Large Options Trading (NASDAQ:XENE) - MarketBeat

Jun 15, 2025
pulisher
Jun 15, 2025

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Receives Average Recommendation of “Buy” from Analysts - Defense World

Jun 15, 2025
pulisher
Jun 13, 2025

Xenon Pharmaceuticals price target raised to $57 from $55 at RBC Capital - Investing.com Canada

Jun 13, 2025
pulisher
Jun 13, 2025

RBC Raises Price Target on Xenon Pharmaceuticals to $57 From $55, Keeps Outperform, Speculative Risk - MarketScreener

Jun 13, 2025
pulisher
Jun 13, 2025

Cantor Fitzgerald Estimates XENE FY2026 Earnings - MarketBeat

Jun 13, 2025
pulisher
Jun 12, 2025

Traders Purchase High Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Xenon Pharmaceuticals (XENE) Up 8.7% Since Last Earnings Report: Can It Continue? - Yahoo Finance

Jun 11, 2025
pulisher
Jun 11, 2025

Brokers Set Expectations for XENE FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Xenon Pharmaceuticals at Goldman Sachs Conference: Strategic Clinical Advances By Investing.com - Investing.com Canada

Jun 10, 2025
pulisher
Jun 10, 2025

Transcript : Xenon Pharmaceuticals Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 03 - MarketScreener

Jun 10, 2025
pulisher
Jun 08, 2025

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Shares Sold by Squarepoint Ops LLC - Defense World

Jun 08, 2025
pulisher
Jun 05, 2025

xenon pharmaceuticals reports shareholder voting results By Investing.com - Investing.com South Africa

Jun 05, 2025
pulisher
Jun 05, 2025

xenon pharmaceuticals reports shareholder voting results - Investing.com

Jun 05, 2025
pulisher
Jun 05, 2025

(XENE) Trading Advice - news.stocktradersdaily.com

Jun 05, 2025
pulisher
Jun 03, 2025

Xenon to Present at the Goldman Sachs 46th Annual Global Healthc - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Xenon Pharmaceuticals to Present at Global Healthcare Conference - TipRanks

Jun 03, 2025
pulisher
Jun 03, 2025

Xenon to Present at the Goldman Sachs 46th Annual Global Healthcare Conference | XENE Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Xenon CEO to Update Investors on Breakthrough Epilepsy Drug at Goldman Sachs Healthcare Conference - Stock Titan

Jun 03, 2025
pulisher
Jun 02, 2025

Stock Traders Buy Large Volume of Xenon Pharmaceuticals Put Options (NASDAQ:XENE) - MarketBeat

Jun 02, 2025
pulisher
Jun 01, 2025

Analyzing Xenon Pharmaceuticals (NASDAQ:XENE) and Inhibitor Therapeutics (OTCMKTS:INTI) - Defense World

Jun 01, 2025
pulisher
May 30, 2025

Xenon Pharmaceuticals Announces Equity Inducement Grants for New Employees - TipRanks

May 30, 2025
pulisher
May 30, 2025

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Lis - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

May 30, 2025
pulisher
May 30, 2025

Xenon Pharmaceuticals Awards $1.5M in Stock Options to 7 New Hires Under Nasdaq Rule - Stock Titan

May 30, 2025
pulisher
May 30, 2025

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Shares Sold by Bank of America Corp DE - Defense World

May 30, 2025
pulisher
May 29, 2025

Xenon Pharmaceuticals Sees Unusually Large Options Volume (NASDAQ:XENE) - Defense World

May 29, 2025
pulisher
May 27, 2025

Ameriprise Financial Inc. Increases Position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World

May 27, 2025
pulisher
May 26, 2025

(XENE) Investment Analysis and Advice - news.stocktradersdaily.com

May 26, 2025
pulisher
May 25, 2025

Northern Trust Corp Raises Stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World

May 25, 2025
pulisher
May 23, 2025

Xenon Pharmaceuticals (NASDAQ:XENE) Rating Lowered to “Sell” at Wall Street Zen - Defense World

May 23, 2025
pulisher
May 21, 2025

Xenon Pharmaceuticals at RBC Capital Markets: Strategic Insights on Ezetucalmer - Investing.com India

May 21, 2025
pulisher
May 21, 2025

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Given Consensus Recommendation of “Buy” by Brokerages - Defense World

May 21, 2025
pulisher
May 20, 2025

Xenon Pharmaceuticals’ SWOT analysis: neurological drug stock faces pivotal year - Investing.com India

May 20, 2025
pulisher
May 18, 2025

Analysts Issue Forecasts for XENE FY2025 Earnings - Defense World

May 18, 2025
pulisher
May 17, 2025

Leerink Partnrs Has Bullish Forecast for XENE Q2 Earnings - Defense World

May 17, 2025
pulisher
May 16, 2025

XENE FY2025 EPS Estimate Decreased by Cantor Fitzgerald - Defense World

May 16, 2025
pulisher
May 16, 2025

What is William Blair’s Estimate for XENE FY2025 Earnings? - Defense World

May 16, 2025
pulisher
May 16, 2025

Wedbush Equities Analysts Cut Earnings Estimates for XENE - Defense World

May 16, 2025
pulisher
May 16, 2025

Xenon Pharmaceuticals (NASDAQ:XENE) Coverage Initiated at Evercore ISI - Defense World

May 16, 2025
pulisher
May 16, 2025

HC Wainwright Issues Optimistic Outlook for XENE Earnings - Defense World

May 16, 2025
pulisher
May 15, 2025

How To Trade (XENE) - news.stocktradersdaily.com

May 15, 2025
pulisher
May 15, 2025

Traders Buy High Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE) - Defense World

May 15, 2025
pulisher
May 15, 2025

Royal Bank of Canada Issues Pessimistic Forecast for Xenon Pharmaceuticals (NASDAQ:XENE) Stock Price - Defense World

May 15, 2025
pulisher
May 15, 2025

Xenon Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:XENE) - Defense World

May 15, 2025
pulisher
May 15, 2025

Chardan Capital Reiterates “Buy” Rating for Xenon Pharmaceuticals (NASDAQ:XENE) - Defense World

May 15, 2025
pulisher
May 15, 2025

Xenon Q1 Loss Narrower Than Expected, Pipeline Development in Focus - MSN

May 15, 2025
pulisher
May 15, 2025

Needham & Company LLC Lowers Xenon Pharmaceuticals (NASDAQ:XENE) Price Target to $55.00 - Defense World

May 15, 2025
pulisher
May 15, 2025

Wells Fargo & Company Has Lowered Expectations for Xenon Pharmaceuticals (NASDAQ:XENE) Stock Price - Defense World

May 15, 2025
pulisher
May 15, 2025

Xenon Pharmaceuticals (NASDAQ:XENE) Stock Rating Upgraded by StockNews.com - Defense World

May 15, 2025
pulisher
May 14, 2025

Evercore ISI Group Initiates Coverage of Xenon Pharmaceuticals (XENE) with Outperform Recommendation - Nasdaq

May 14, 2025

Xenon Pharmaceuticals Inc (XENE) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Xenon Pharmaceuticals Inc 주식 (XENE) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
GANNON STEVEN
Director
May 14 '25
Option Exercise
12.57
5,144
64,660
7,144
MORTIMER IAN
PRESIDENT & CEO
Jan 24 '25
Option Exercise
17.76
22,468
399,032
53,770
MORTIMER IAN
PRESIDENT & CEO
Jan 27 '25
Option Exercise
17.76
16,315
289,754
46,468
MORTIMER IAN
PRESIDENT & CEO
Jan 23 '25
Option Exercise
17.76
16,217
288,014
47,519
MORTIMER IAN
PRESIDENT & CEO
Jan 24 '25
Sale
40.20
22,468
903,214
31,302
MORTIMER IAN
PRESIDENT & CEO
Jan 27 '25
Sale
40.50
16,315
660,806
31,302
MORTIMER IAN
PRESIDENT & CEO
Jan 23 '25
Sale
40.08
16,217
649,977
31,302
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
자본화:     |  볼륨(24시간):